{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:52:06Z","timestamp":1777452726671,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Therapy"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:p>Direct-acting antiviral (DAA) combinations are potent and effective drugs currently recommended for treatment of chronic HCV infection. Difficult to treat genotypes are the most important predictors of treatment failure. We report a case of DAA treatment failure in an HCV-infected patient carrying a recombinant genotype 2k\/1b. This strain, first isolated from a Russian patient in 2002, has now been observed for the first time in Italy.<\/jats:p>","DOI":"10.3851\/imp3130","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T10:59:32Z","timestamp":1484305172000},"page":"365-368","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":5,"title":["HCV Intergenotype 2k\/1b Recombinant Detected in a DAA-Treated Patient in Italy"],"prefix":"10.1177","volume":"22","author":[{"given":"Stefania","family":"Paolucci","sequence":"first","affiliation":[{"name":"Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Premoli","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Ludovisi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario U","family":"Mondelli","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medical Sciences and Infectious Diseases, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"},{"name":"Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Baldanti","sequence":"additional","affiliation":[{"name":"Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy"},{"name":"Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,5,1]]},"reference":[{"key":"bibr1-IMP3130","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2016.1182156"},{"key":"bibr2-IMP3130","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01367.x"},{"key":"bibr3-IMP3130","doi-asserted-by":"publisher","DOI":"10.1586\/egh.09.60"},{"key":"bibr4-IMP3130","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26744"},{"key":"bibr5-IMP3130","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-78-2-321"},{"key":"bibr6-IMP3130","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.8.4034-4043.2002"},{"key":"bibr7-IMP3130","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.19472-0"},{"key":"bibr8-IMP3130","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20714"},{"key":"bibr9-IMP3130","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00312-06"},{"key":"bibr10-IMP3130","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02639-06"},{"key":"bibr11-IMP3130","doi-asserted-by":"publisher","DOI":"10.4137\/EBO.S1038"},{"key":"bibr12-IMP3130","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-6-203"},{"key":"bibr13-IMP3130","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21658"},{"key":"bibr14-IMP3130","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21955"},{"key":"bibr15-IMP3130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"bibr16-IMP3130","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-9-245"},{"key":"bibr17-IMP3130","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-355"},{"key":"bibr18-IMP3130","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0197(96)00242-5"},{"key":"bibr19-IMP3130","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msr121"},{"key":"bibr20-IMP3130","doi-asserted-by":"publisher","DOI":"10.1093\/sysbio\/syq010"},{"key":"bibr21-IMP3130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091384"}],"container-title":["Antiviral Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP3130","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP3130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:52:13Z","timestamp":1777380733000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3851\/IMP3130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.3851\/IMP3130"],"URL":"https:\/\/doi.org\/10.3851\/imp3130","relation":{},"ISSN":["1359-6535","2040-2058"],"issn-type":[{"value":"1359-6535","type":"print"},{"value":"2040-2058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,1]]}}}